BRPI0620212B8 - método de discriminação e de contagem de pelo menos duas populações de elementos biológicos portadoras de características específicas, e, utilização do método - Google Patents

método de discriminação e de contagem de pelo menos duas populações de elementos biológicos portadoras de características específicas, e, utilização do método

Info

Publication number
BRPI0620212B8
BRPI0620212B8 BRPI0620212A BRPI0620212A BRPI0620212B8 BR PI0620212 B8 BRPI0620212 B8 BR PI0620212B8 BR PI0620212 A BRPI0620212 A BR PI0620212A BR PI0620212 A BRPI0620212 A BR PI0620212A BR PI0620212 B8 BRPI0620212 B8 BR PI0620212B8
Authority
BR
Brazil
Prior art keywords
populations
biological elements
discrimination
counting
specific characteristics
Prior art date
Application number
BRPI0620212A
Other languages
English (en)
Inventor
Lefevre Didier
Belloc Francis
Lacombe Francis
Veriac Sylvie
Original Assignee
Horiba Abx Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horiba Abx Sas filed Critical Horiba Abx Sas
Publication of BRPI0620212A2 publication Critical patent/BRPI0620212A2/pt
Publication of BRPI0620212B1 publication Critical patent/BRPI0620212B1/pt
Publication of BRPI0620212B8 publication Critical patent/BRPI0620212B8/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/016White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N2015/1006Investigating individual particles for cytology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1477Multiparameters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/13Tracers or tags

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Ecology (AREA)
  • Dispersion Chemistry (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

método de discriminação e de contagem de pelo menos duas populações de elementos biológicos portadoras de características específicas, e, utilização do método. a invenção tem como objeto um método de discriminação e de contagem de pelo menos duas populações de elementos biológicos portadoras de características específicas, eventualmente presentes em uma amostra. a invenção permite a detecção sem ambiquidade de pelo menos três populações de elementos biológicos pela utilização de somente dois meios de detecção, o que implica que pelo menos duas populações de elementos biológicos sejam detectadas por um único e mesmo meio de detecção. a invenção pode ser realizada se são utilizadas três sondas diferentes, cada uma delas reconhecendo e se fixando a uma das populações de elementos biológicos a detectar, cada uma das sondas sendo ela própria tornada detectável por um marcador diferente, dois dos ditos marcadores diferentes apresentado dois espectros de emissão que têm pelo menos uma parte comum (espectros de emissão superpostos) e o terceiro aparesentando um espectro de emissão que não tem essencialmente nenhuma parte comum com os dois outros (espectro não superposto).
BRPI0620212A 2005-12-20 2006-12-05 método de discriminação e de contagem de pelo menos duas populações de elementos biológicos portadoras de características específicas, e, utilização do método BRPI0620212B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0512948 2005-12-20
FR0512948A FR2895087B1 (fr) 2005-12-20 2005-12-20 Methode de discrimination d'au moins deux populations cellulaires et application
PCT/FR2006/002645 WO2007080245A1 (fr) 2005-12-20 2006-12-05 Methode de discrimination d'au moins deux populations cellulaires et application

Publications (3)

Publication Number Publication Date
BRPI0620212A2 BRPI0620212A2 (pt) 2013-01-15
BRPI0620212B1 BRPI0620212B1 (pt) 2018-02-14
BRPI0620212B8 true BRPI0620212B8 (pt) 2021-07-27

Family

ID=36259085

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0620212A BRPI0620212B8 (pt) 2005-12-20 2006-12-05 método de discriminação e de contagem de pelo menos duas populações de elementos biológicos portadoras de características específicas, e, utilização do método

Country Status (14)

Country Link
US (1) US8080383B2 (pt)
EP (1) EP1963859B1 (pt)
JP (1) JP4782844B2 (pt)
KR (1) KR20080082650A (pt)
CN (1) CN101375164B (pt)
AT (1) ATE490468T1 (pt)
BR (1) BRPI0620212B8 (pt)
CA (1) CA2632343A1 (pt)
DE (1) DE602006018653D1 (pt)
ES (1) ES2357035T3 (pt)
FR (1) FR2895087B1 (pt)
RU (1) RU2397494C2 (pt)
WO (1) WO2007080245A1 (pt)
ZA (1) ZA200804642B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2935802B1 (fr) * 2008-09-05 2012-12-28 Horiba Abx Sas Procede et dispositif de classification, de visualisation et d'exploration de donnees biologiques
JP5452058B2 (ja) * 2009-03-31 2014-03-26 シスメックス株式会社 血液分析装置
FR2956207B1 (fr) 2010-02-10 2012-05-04 Horiba Abx Sas Dispositif et procede de mesures multiparametriques de microparticules dans un fluide
US20120173296A1 (en) * 2011-01-03 2012-07-05 Mcmullin Dale Robert Method and system for outage restoration
RU2513511C1 (ru) * 2012-12-19 2014-04-20 Федеральное государственное бюджетное учреждение "Российский онкологический научный центр имени Н.Н. Блохина" Российской академии медицинских наук (ФГБУ "РОНЦ им. Н.Н. Блохина" РАМН) Способ количественного определения клеток-предшественников (cd34+) в кроветворной ткани
US20140349313A1 (en) * 2013-04-30 2014-11-27 Becton, Dickinson And Company Data analysis methods utilizing phenotypic properties
CN104792751B (zh) * 2015-04-02 2017-06-23 清华大学 通过荧光共振能量转移方法原位定量活细胞中的蛋白质‑蛋白质相互作用
CN108732082A (zh) * 2018-06-07 2018-11-02 北京唯公医疗技术有限公司 细胞分群方法
US11428692B2 (en) 2018-07-11 2022-08-30 Visiongate, Inc. Specimen enrichment for optical tomography cell analysis
US10753875B1 (en) * 2019-01-31 2020-08-25 Rarecyte, Inc. Spectral unmixing of spectroscopic emission images
CN110231275B (zh) * 2019-05-20 2021-05-28 西安交通大学 一种基于流式细胞术检测nk细胞杀伤活性的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08510051A (ja) * 1993-01-08 1996-10-22 クールター コーポレイション 保存対照細胞を蛍光および光散乱測定の校正において用いる方法
GR940100272A (en) * 1993-06-08 1995-11-29 Ortho Diagnostic Systems Inc Three-colour flow cytometry with automatic gating function.
US6900023B1 (en) * 1999-09-02 2005-05-31 Sysmex Corporation Method for classifying and counting leukocytes
WO2003016866A2 (en) * 2001-08-16 2003-02-27 Litron Laboratories Ltd Method for the enumeration of mammalian micronucleated erythrocyte populations with a single-laser flow cytometer
US7625712B2 (en) * 2004-05-21 2009-12-01 Beckman Coulter, Inc. Method for a fully automated monoclonal antibody-based extended differential

Also Published As

Publication number Publication date
RU2008129429A (ru) 2010-01-27
DE602006018653D1 (de) 2011-01-13
EP1963859A1 (fr) 2008-09-03
KR20080082650A (ko) 2008-09-11
ES2357035T3 (es) 2011-04-15
BRPI0620212A2 (pt) 2013-01-15
ATE490468T1 (de) 2010-12-15
US8080383B2 (en) 2011-12-20
FR2895087A1 (fr) 2007-06-22
WO2007080245A1 (fr) 2007-07-19
US20090311678A1 (en) 2009-12-17
JP4782844B2 (ja) 2011-09-28
EP1963859B1 (fr) 2010-12-01
CA2632343A1 (fr) 2007-07-19
ZA200804642B (en) 2009-04-29
CN101375164A (zh) 2009-02-25
FR2895087B1 (fr) 2008-02-08
BRPI0620212B1 (pt) 2018-02-14
JP2009520198A (ja) 2009-05-21
CN101375164B (zh) 2014-01-01
RU2397494C2 (ru) 2010-08-20

Similar Documents

Publication Publication Date Title
BRPI0620212B8 (pt) método de discriminação e de contagem de pelo menos duas populações de elementos biológicos portadoras de características específicas, e, utilização do método
BR112013003391A2 (pt) biomarcadores de câncer pancreático e usos dos mesmos
BR112014006432A2 (pt) biomarcadores do câncer de pulmão e seus usos
BR112012032537B8 (pt) Métodos para diagnosticar se um indivíduo tem ou não câncer de pulmão de não pequenas células, ou para fornecer informações sobre câncer de pulmão de não pequenas células em um indivíduo
PH12018550037A1 (en) Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof
MY192493A (en) Urinalysis device and dry reagent for quantitative urinalysis
WO2008048230A3 (en) Methods of identifying biological targets and instrumentation to identify biological targets
BRPI0407397A (pt) Evento de algodão mon 88913 e composições e métodos para sua detecção
HK1088947A1 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
BRPI0700056A (pt) sistema automatizado para processar amostras biológicas e método
BRPI0713375A2 (pt) dispositivo de ensaio descartável, e, método de ensaio
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE554389T1 (de) Apex als marker für lungenkrebs
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
BRPI0607194A2 (pt) método para analisar quantitativamente um microorganismo por marcação de rrna
BRPI0811930B8 (pt) métodos e kit diagnóstico ou prognóstico de lúpus em um indivíduo
DE602006018895D1 (de) Analyse von atemprobe auf pentylfuran
UY33058A (es) Detección del evento de soja aad-12 416
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
WO2016196993A8 (en) Multi-mediator reagent formulations for use in electrochemical detection
WO2016198833A3 (en) Methods for analysing a urine sample
BR112014018717A8 (pt) Método para selecionar ou identificar um sujeito para terapia de antagonista de v1b
CY1121482T1 (el) Ευαισθητη πολυπλεκτικη ανοσοδοκιμασια για τους διαλυτους υποδοχεις των αυξητικων παραγοντων των ινοβλαστων
WO2016019217A8 (en) Compositions, methods and devices thereof for fluorescent analysis of gunshot residue

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/12/2006, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2699 DE 27-09-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.